Ignite Creation Date:
2025-12-24 @ 10:34 PM
Ignite Modification Date:
2025-12-25 @ 8:06 PM
Study NCT ID:
NCT00760435
Status:
COMPLETED
Last Update Posted:
2014-11-24
First Post:
2008-09-25
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease
Sponsor:
University of California, San Diego
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
1R01FD003514-01
Study Type:
FDA
Study Domain:
None
Study Link:
https://reporter.nih.gov/quickSearch/1R01FD003514-01
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |